[1]
|
Couser, W.G. (2017) Primary Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 12, 983-997. https://doi.org/10.2215/CJN.11761116
|
[2]
|
Ronco, P., Plaisier, E. and Debiec, H. (2021) Advances in Membranous Nephropathy. Journal of Clinical Medicine, 10, 607. https://doi.org/10.3390/jcm10040607
|
[3]
|
Lai, W.L., Yeh, T.H., Chen, P.M., et al. (2015) Membranous Nephropathy: A Review on the Pathogenesis, Diagnosis, and Treatment. Journal of the Formosan Medical Association, 114, 102-111.
https://doi.org/10.1016/j.jfma.2014.11.002
|
[4]
|
Ruggenenti, P., Fervenza, F.C. and Remuzzi, G. (2017) Treatment of Membranous Nephropathy: Time for a Paradigm Shift. Nature Reviews Nephrology, 13, 563-579. https://doi.org/10.1038/nrneph.2017.92
|
[5]
|
Xu, X., Wang, G., Chen, N., et al. (2016) Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China. Journal of the American Society of Nephrology, 27, 3739-3746.
https://doi.org/10.1681/ASN.2016010093
|
[6]
|
Zhu, P., Zhou, F.D., Wang, S.X., et al. (2015) Increasing Fre-quency of Idiopathic Membranous Nephropathy in Primary Glomerular Disease: A 10-Year Renal Biopsy Study from a Single Chinese Nephrology Centre. Nephrology (Carlton), 20, 560-566. https://doi.org/10.1111/nep.12542
|
[7]
|
Alsharhan, L. and Beck Jr., L.H. (2021) Membranous Nephropathy: Core Curriculum 2021. American Journal of Kidney Diseases, 77, 440-453. https://doi.org/10.1053/j.ajkd.2020.10.009
|
[8]
|
Beck Jr., L.H., Bonegio, R.G., Lambeau, G., et al. (2009) M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy. The New England Journal of Medicine, 361, 11-21.
https://doi.org/10.1056/NEJMoa0810457
|
[9]
|
Tomas, N.M., Beck Jr., L.H., Meyer-Schwesinger, C., et al. (2014) Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy. The New England Journal of Medicine, 371, 2277-2287.
https://doi.org/10.1056/NEJMoa1409354
|
[10]
|
Debiec, H., Guigonis, V., Mougenot, B., et al. (2002) Antenatal Membranous Glomerulonephritis Due to Anti-Neutral Endopeptidase Antibodies. The New England Journal of Medicine, 346, 2053-2060.
https://doi.org/10.1056/NEJMoa012895
|
[11]
|
Sethi, S., Madden, B.J., Debiec, H., et al. (2019) Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. Journal of the American Society of Nephrology, 30, 1123-1136. https://doi.org/10.1681/ASN.2018080852
|
[12]
|
Sethi, S., Debiec, H., Madden, B., et al. (2020) Neural Epidermal Growth Factor-Like 1 Protein (NELL-1) Associated Membranous Nephropathy. Kidney International, 97, 163-174. https://doi.org/10.1016/j.kint.2019.09.014
|
[13]
|
Sethi, S., Debiec, H., Madden, B., et al. (2020) Semaphorin 3B-Associated Membranous Nephropathy Is a Distinct Type of Disease Predominantly Present in Pediatric Patients. Kidney International, 98, 1253-1264.
https://doi.org/10.1016/j.kint.2020.05.030
|
[14]
|
Caza, T.N., Hassen, S.I., Kuperman, M., et al. (2021) Neural Cell Adhesion Molecule 1 Is a Novel Autoantigen in Membranous Lupus Nephritis. Kidney International, 100, 171-181. https://doi.org/10.1016/j.kint.2020.09.016
|
[15]
|
Caza, T.N., Hassen, S.I., Kenan, D.J., Storey, A., Arthur, J.M., et al. (2021) Transforming Growth Factor Beta Receptor 3 (TGFBR3)-Associated Membranous Nephropathy. Kidney360, 2, 1275-1286.
https://doi.org/10.34067/KID.0001492021
|
[16]
|
Sethi, S., Madden, B., Debiec, H., et al. (2021) Protocadherin 7-Associated Membranous Nephropathy. Journal of the American Society of Nephrology, 32, 1249-1261. https://doi.org/10.1681/ASN.2020081165
|
[17]
|
Al-Rabadi, L.F., Caza, T., Trivin-Avillach, C., et al. (2021) Serine Protease HTRA1 as a Novel Target Antigen in Primary Membranous Nephropathy. Journal of the American Society of Nephrology, 32, 1666-1681.
https://doi.org/10.1681/ASN.2020101395
|
[18]
|
Reinhard, L., Machalitza, M., Wiech, T., et al. (2022) Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy. Journal of the American Society of Nephrology, 33, 1823-1831.
https://doi.org/10.1681/ASN.2022050608
|
[19]
|
Sethi, S., Madden, B., Casal Moura, M., et al. (2022) Hematopoi-etic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1. Journal of the American Society of Nephrology, 33, 1033-1044.
https://doi.org/10.1681/ASN.2021111488
|
[20]
|
Le Quintrec, M., Teisseyre, M., Bec, N., et al. (2021) Contactin-1 Is a Novel Target Antigen in Membranous Nephropathy Associated with Chronic Inflammatory Demyelinating Polyneu-ropathy. Kidney International, 100, 1240-1249.
https://doi.org/10.1016/j.kint.2021.08.014
|
[21]
|
Li, J., Cui, Z., Long, J., et al. (2018) Primary Glomerular Nephrop-athy among Hospitalized Patients in a National Database in China. Nephrology Dialysis Transplantation, 33, 2173-2181. https://doi.org/10.1093/ndt/gfy022
|
[22]
|
王凯. 单中心3899例肾活检患者临床与病理特征分析[D]: [硕士学位论文]. 长春: 吉林大学, 2020.
|
[23]
|
Hou, J.H., Zhu, H.X., Zhou, M.L., et al. (2018) Changes in the Spectrum of Kid-ney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China. Kidney Disease (Basel), 4, 10-19.
https://doi.org/10.1159/000484717
|
[24]
|
Nie, S., He, W., Huang, T., et al. (2018) The Spectrum of Biopsy-Proven Glomerular Diseases among Children in China: A National, Cross-Sectional Survey. Clinical Journal of the American Society of Nephrology, 13, 1047-1054.
https://doi.org/10.2215/CJN.11461017
|
[25]
|
谢志勇, 李志莲, 董伟, 等. 慢性肾小球疾病谱演变和膜性肾病流行病学特点[J]. 临床肾脏病杂志, 2019, 19(7): 471-476+492.
|
[26]
|
Ponticelli, C. and Passerini, P. (2010) Can Prog-nostic Factors Assist Therapeutic Decisions in Idiopathic Membranous Nephropathy? Journal of Nephrology, 23, 156-163.
|
[27]
|
Keri, K.C., Blumenthal, S., Kulkarni, V., et al. (2019) Primary Membranous Nephropathy: Comprehen-sive Review and Historical Perspective. Postgraduate Medical Journal, 95, 23-31. https://doi.org/10.1136/postgradmedj-2018-135729
|
[28]
|
Hofstra, J.M., Fervenza, F.C. and Wetzels, J.F. (2013) Treatment of Idiopathic Membranous Nephropathy. Nature Reviews Nephrology, 9, 443-458. https://doi.org/10.1038/nrneph.2013.125
|
[29]
|
Jennette, J.C., Iskandar, S.S. and Dalldorf, F.G. (1983) Pathologic Differentiation between Lupus and Nonlupus Membranous Glomerulopathy. Kidney International, 24, 377-385. https://doi.org/10.1038/ki.1983.170
|
[30]
|
Debiec, H., Guigonis, V., Mougenot, B., et al. (2003) Antenatal Mem-branous Glomerulonephritis with Vascular Injury Induced by Anti-Neutral Endopeptidase Antibodies: Toward New Concepts in the Pathogenesis of Glomerular Diseases. Journal of the American Society of Nephrology, 14, S27-S32.
https://doi.org/10.1097/01.ASN.0000067649.64849.75
|
[31]
|
Debiec, H., Nauta, J., Coulet, F., et al. (2004) Role of Truncating Mutations in MME Gene in Fetomaternal Alloimmunisation and Antenatal Glomerulopathies. The Lancet, 364, 1252-1259.
https://doi.org/10.1016/S0140-6736(04)17142-0
|
[32]
|
Vivarelli, M., Emma, F., Pellé, T., et al. (2015) Genetic Ho-mogeneity but IgG Subclass-Dependent Clinical Variability of Alloimmune Membranous Nephropathy with Anti-Neutral Endopeptidase Antibodies. Kidney International, 87, 602-609. https://doi.org/10.1038/ki.2014.381
|
[33]
|
Hoxha, E., Kneißler, U., Stege, G., et al. (2012) Enhanced Expression of the M-Type Phospholipase A2 Receptor in Glomeruli Cor-relates with Serum Receptor Antibodies in Primary Membranous Nephropathy. Kidney International, 82, 797-804. https://doi.org/10.1038/ki.2012.209
|
[34]
|
Beck Jr., L.H. and Salant, D.J. (2010) Membranous Nephropathy: Recent Travels and New Roads Ahead. Kidney International, 77, 765-770. https://doi.org/10.1038/ki.2010.34
|
[35]
|
Ronco, P. and Debiec, H. (2014) Anti-Phospholipase A2 Receptor Antibodies and the Pathogenesis of Membranous Nephropa-thy. Nephron Clinical Practice, 128, 232-237. https://doi.org/10.1159/000368588
|
[36]
|
Hofstra, J.M., Beck Jr., L.H., Beck, D.M., et al. (2011) Anti-Phospholipase A₂ Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy. Clinical Journal of the American Society of Nephrology, 6, 1286-1291. https://doi.org/10.2215/CJN.07210810
|
[37]
|
Brglez, V., Boyer-Suavet, S., Zorzi, K., et al. (2020) Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial. Frontiers in Medi-cine (Lausanne), 7, 412.
https://doi.org/10.3389/fmed.2020.00412
|
[38]
|
Seitz-Polski, B., Dolla, G., Payré, C., et al. (2016) Epitope Spread-ing of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy. Journal of the American Society of Nephrology, 27, 1517-1533.
https://doi.org/10.1681/ASN.2014111061
|
[39]
|
KDIGO (2021) Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International, 100, S1-S276. https://doi.org/10.1016/j.kint.2021.05.021
|
[40]
|
Xian, L., Dong, D., Luo, J., et al. (2019) Expression of THSD7A in Neoplasm Tissues and Its Relationship with Proteinuria. BMC Nephrology, 20, 332. https://doi.org/10.1186/s12882-019-1489-5
|
[41]
|
Hoxha, E., Wiech, T., Stahl, P.R., et al. (2016) A Mechanism for Cancer-Associated Membranous Nephropathy. The New England Journal of Medicine, 374, 1995-1996. https://doi.org/10.1056/NEJMc1511702
|
[42]
|
Hoxha, E., Beck Jr., L.H., Wiech, T., et al. (2017) An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. Journal of the American Society of Nephrology, 28, 520-531. https://doi.org/10.1681/ASN.2016010050
|
[43]
|
Sharma, S.G. and Larsen, C.P. (2018) Tissue Staining for THSD7A in Glomeruli Correlates with Serum Antibodies in Primary Membranous Nephropathy: A Clinicopathological Study. Modern Pathology, 31, 616-622.
https://doi.org/10.1038/modpathol.2017.163
|
[44]
|
Wang, G., Sun, L., Dong, H., et al. (2021) Neural Epidermal Growth Factor-Like 1 Protein-Positive Membranous Nephropathy in Chinese Patients. Clinical Journal of the American Society of Nephrology, 16, 727-735.
https://doi.org/10.2215/CJN.11860720
|
[45]
|
Caza, T.N., Hassen, S.I., Dvanajscak, Z., et al. (2021) NELL1 Is a Target Antigen in Malignancy-Associated Membranous Nephropathy. Kidney International, 99, 967-976. https://doi.org/10.1016/j.kint.2020.07.039
|
[46]
|
Fila, M., Debiec, H., Perrochia, H., et al. (2022) Recurrence of An-ti-Semaphorin 3B-Mediated Membranous Nephropathy after Kidney Transplantation. Journal of the American Society of Nephrology, 33, 503-509.
https://doi.org/10.1681/ASN.2021101323
|
[47]
|
Busse, M., Feta, A., Presto, J., et al. (2007) Contribution of EXT1, EXT2, and EXTL3 to Heparan Sulfate Chain Elongation. Journal of Biological Chemistry, 282, 32802-32810. https://doi.org/10.1074/jbc.M703560200
|
[48]
|
Iwakura, T., Ema, C., Isobe, S., et al. (2022) Prevalence of Neural Epidermal Growth Factor-Like 1- and Exostosin 1/Exostosin 2-Associated Membranous Nephropathy: A Single-Center Retrospective Study in Japan. Scientific Reports, 12, Article No. 2967. https://doi.org/10.1038/s41598-022-07037-2
|
[49]
|
Wada, Y., Iyoda, M., Suzuki, T., et al. (2021) Immunopatholog-ical Analysis of the Expression of Glomerular Exostosin 1 and Exostosin 2 in Japanese Patients with Lupus Nephritis. Virchows Archiv, 479, 997-1005.
https://doi.org/10.1007/s00428-021-03164-9
|
[50]
|
Ward, F. and Bargman, J.M. (2016) Membranous Lupus Ne-phritis: The Same, But Different. American Journal of Kidney Diseases, 68, 954-966. https://doi.org/10.1053/j.ajkd.2016.07.026
|
[51]
|
Iwakura, T., Ema, C., Sato, T., et al. (2021) Primary Membranous Nephropathy with Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases. Kidney Medi-cine, 3, 669-673.
https://doi.org/10.1016/j.xkme.2021.03.013
|
[52]
|
Troxell, M.L., Higgins, J.P. and Kambham, N. (2014) Renal Pa-thology Associated with Hematopoietic Stem Cell Transplantation. Advances in Anatomic Pathology, 21, 330-340. https://doi.org/10.1097/PAP.0000000000000034
|
[53]
|
Plaisier, E., Not, A., Buob, D., et al. (2021) Contac-tin-1-Associated Membranous Nephropathy: Complete Immunologic and Clinical Remission with Rituximab. Kidney In-ternational, 100, 1342-1344.
https://doi.org/10.1016/j.kint.2021.08.029
|